46.46.Z - Wholesale trade of pharmaceutical and medical products
01.16.Z - Cultivation of fiber plants
01.28.Z - Cultivation of spice, aromatic plants and plants used for pharmaceuticals
10.89.Z - Production of other food products, not elsewhere classified
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
72.11.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -1,7 | -6,1 | -1,1 | 82,2 |
EBITDA | -1,7 | -4,2 | -1 | 76,1 |
Short time liabilities | 0,4 | 2,3 | 2,1 | -8,8 |
Equity capital | 13,1 | 4,3 | 3,2 | -25,7 |
Operating profit (EBIT) | -1,7 | -4,2 | -1,1 | 74,4 |
Assets | 13,7 | 7,9 | 8,9 | 11,8 |
Net profit (loss) | -1,7 | -6,1 | -1,1 | 82,2 |
Cash | 0,2 | 0,1 | 1 | 694,7 |
Net income from sale | 3 | 0,7 | 1,8 | 176,8 |
Liabilities and provisions for liabilities | 0,6 | 3,7 | 5,7 | 55 |
Working assets | 3,6 | 0,4 | 1,5 | 269,3 |
Depreciation | 0 | 0 | 0,1 | 732,8 |
% | % | % | p.p. | |
Profitability of capital | -13 | -143,9 | -34,4 | 109,5 |
Equity capital to total assets | 95,6 | 53,5 | 35,6 | -17,9 |
Gross profit margin | -56,5 | -923,5 | -59,3 | 864,2 |
EBITDA Margin | -56,7 | -638,7 | -55 | 583,7 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 48 | 1274 | 420 | -854 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane